508
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Serotypes, virulence and antimicrobial susceptibility of Group B Streptococci isolated from infections in non-pregnant adults in Malaysia

, , , & ORCID Icon
Article: 2241706 | Received 14 Feb 2022, Accepted 16 Jul 2023, Published online: 02 Aug 2023

References

  • Camuset G, Picot S, Jaubert J, et al. Invasive group B streptococcal disease in non-pregnant adults, Reunion Island, 2011. Int J Infect Dis. 2015;35:46–50. doi: 10.1016/j.ijid.2015.04.006. PubMed PMID: 25892248.
  • Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis. 2005;41(6):839–847. doi: 10.1086/432804. PubMed PMID: 16107984.
  • Kothari NJ, Morin CA, Glennen A, et al. Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003–2007. Emerg Infect Dis. 2009;15(8):1279–1281. doi: 10.3201/eid1508.081381. PubMed PMID: 19751591; PubMed Central PMCID: PMCPMC2815956.
  • Francois Watkins LK, McGee L, Schrag SJ, et al. Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008–2016. JAMA Intern Med. 2019;179(4):479–488. doi: 10.1001/jamainternmed.2018.7269. PubMed PMID: 30776079.
  • Karunakaran R, Raja NS, Hafeez A, et al. Group B streptococcus infection: epidemiology, serotypes, and antimicrobial susceptibility of selected isolates in the population beyond infancy (excluding females with genital tract- and pregnancy-related isolates) at the University Malaya Medical Centre, Kuala Lumpur. Jpn J Infect Dis. 2009;62(3):192–194. doi: 10.7883/yoken.JJID.2009.192. PubMed PMID: 19468178.
  • Lopes E, Fernandes T, Machado MP, et al. Increasing macrolide resistance among Streptococcus agalactiae causing invasive disease in non-pregnant adults was driven by a single capsular-transformed lineage, Portugal, 2009 to 2015. Euro Surveill. 2018;23(21). doi: 10.2807/1560-7917.ES.2018.23.21.1700473. PubMed PMID: 29845930; PubMed Central PMCID: PMCPMC6152215.
  • Paveenkittiporn W, Ungcharoen R, Kerdsin A. Streptococcus agalactiae infections and clinical relevance in adults, Thailand. Diagn Microbiol Infect Dis. 2020;97(1):115005), doi: 10.1016/j.diagmicrobio.2020.115005. PubMed PMID: 32081521.
  • Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019;7(2). doi: 10.1128/microbiolspec.GPP3-0007-2018. PubMed PMID: 30900541; PubMed Central PMCID: PMCPMC6432937.
  • Chaiwarith R, Jullaket W, Bunchoo M, et al. Streptococcus agalactiae in adults at Chiang Mai university hospital: a retrospective study. BMC Infect Dis. 2011;11:149, doi: 10.1186/1471-2334-11-149. PubMed PMID: 21612629; PubMed Central PMCID: PMCPMC3123213.
  • High KP, Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Diseas. 2005;41(6):839–847. doi: 10.1086/432804.
  • Farley MM, Strasbaugh LJ. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis. 2001;33(4):556–561. doi: 10.1086/322696. PubMed PMID: 11462195.
  • Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin Infect Dis. 2009;49(1):85–92. doi: 10.1086/599369. PubMed PMID: 19480572.
  • Kalimuddin S, Chen SL, Lim CTK, et al. Epidemic of severe Streptococcus agalactiae sequence type 283 infections in Singapore associated with the consumption of raw freshwater fish: A detailed analysis of clinical, epidemiological, and bacterial sequencing data. Clin Infect Dis. 2015;64(suppl_2):S145–SS52. doi: 10.1093/cid/cix021. Epub 2017/05/06. PubMed PMID: 28475781.
  • Barkham T, Zadoks RN, Azmai MNA, et al. One hypervirulent clone, sequence type 283, accounts for a large proportion of invasive Streptococcus agalactiae isolated from humans and diseased tilapia in Southeast Asia. PLoS Negl Trop Dis. 2019;13(6):e0007421, doi: 10.1371/journal.pntd.0007421. Epub 2019/06/28. PubMed PMID: 31246981; PubMed Central PMCID: PMCPMC6597049 following competing interests: SLC and TB are named applicants on a patent for the ST83-specific PCR test used in this study.
  • Tan S, Lin Y, Foo K, et al. Group B Streptococcus serotype III sequence type 283 bacteremia associated with consumption of Raw fish, Singapore. Emerg Infect Dis. 2016;22(11):1970–1973. doi: 10.3201/eid2211.160210. Epub 2016/10/22. PubMed PMID: 27767904; PubMed Central PMCID: PMCPMC5088028.
  • Eskandarian N, Ismail Z, Neela V, et al. Antimicrobial susceptibility profiles, serotype distribution and virulence determinants among invasive, non-invasive and colonizing Streptococcus agalactiae (group B streptococcus) from Malaysian patients. Eur J Clin Microbiol Infect Dis. 2015;34(3):579–584. doi: 10.1007/s10096-014-2265-x. PubMed PMID: 25359580; PubMed Central PMCID: PMCPMC4356882.
  • Ruppen C, Notter J, Strahm C, et al. Osteoarticular and skin and soft-tissue infections caused by Streptococcus agalactiae in elderly patients are frequently associated with bacteremia. Diagn Microbiol Infect Dis. 2018;90(1):55–57. doi: 10.1016/j.diagmicrobio.2017.09.008 PubMed PMID: 29107417.
  • Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland emerging infections program. J Infect Dis. 1998;177(4):998–1002. doi: 10.1086/515260. PubMed PMID: 9534974.
  • Suhaimi MES, Desa MNM, Eskandarian N, et al. Characterization of a Group B Streptococcus infection based on the demographics, serotypes, antimicrobial susceptibility and genotypes of selected isolates from sterile and non-sterile isolation sites in three major hospitals in Malaysia. J Infect Public Health. 2017;10(1):14–21. doi: 10.1016/j.jiph.2016.01.009 PubMed PMID: 27095302.
  • Dutra VG, Alves VM, Olendzki AN, et al. Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility. BMC Infect Dis. 2014;14:323, doi: 10.1186/1471-2334-14-323 PubMed PMID: 24919844; PubMed Central PMCID: PMCPMC4061772.
  • Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299(17):2056–2065. doi: 10.1001/jama.299.17.2056. Epub 2008/05/08 PubMed PMID: 18460666.
  • Le Doare K, Heath PT. An overview of global GBS epidemiology. Vaccine. 2013;31(Suppl 4):D7–12. doi: 10.1016/j.vaccine.2013.01.009. Epub 2013/08/30. PubMed PMID: 23973349.
  • Jannati E, Roshani M, Arzanlou M, et al. Capsular serotype and antibiotic resistance of group B streptococci isolated from pregnant women in Ardabil, Iran. Iran J Microbiol. 2012;4(3):130–135. Epub 2012/10/16. PubMed PMID: 23066487; PubMed Central PMCID: PMCPMC3465538.
  • Choi SJ, Kang J, Uh Y. Recent epidemiological changes in group B Streptococcus among pregnant Korean women. Ann Lab Med. 2021;41(4):380–385. doi: 10.3343/alm.2021.41.4.380. Epub 2021/02/05. PubMed PMID: 33536356; PubMed Central PMCID: PMCPMC7884197.
  • Björnsdóttir ES, Martins ER, Erlendsdóttir H, et al. Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975–2014. Clin Microbiol Infect. 2016;22(4):379.e9–379e16. https://doi.org/10.1016/j.cmi.2015.11.020.
  • Nuccitelli A, Rinaudo CD, Maione D. Group B Streptococcus vaccine: state of the art. Ther Adv Vaccines. 2015;3(3):76–90. doi: 10.1177/2051013615579869. Epub 2015/08/20. PubMed PMID: 26288735; PubMed Central PMCID: PMCPMC4530403.
  • Udo EE, Boswihi SS, Al-Sweih N. Genotypes and virulence genes in group B streptococcus isolated in the maternity hospital, Kuwait. Med Princ Pract. 2013;22(5):453–457. doi: 10.1159/000349932 PubMed PMID: 23571853; PubMed Central PMCID: PMCPMC5586775.
  • Lee NY, Yan JJ, Wu JJ, et al. Group B streptococcal soft tissue infections in non-pregnant adults. Clin Microbiol Infect. 2005;11(7):577–579. doi: 10.1111/j.1469-0691.2005.01186.x. PubMed PMID: 15966977.
  • Manning SD, Neighbors K, Tallman PA, et al. Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin Infect Dis. 2004;39(3):380–388. doi: 10.1086/422321. PubMed PMID: 15307006.
  • Shabayek S, Spellerberg B. Group B streptococcal colonization, molecular characteristics, and epidemiology. Front Microbiol. 2018;9:437, doi: 10.3389/fmicb.2018.00437. Epub 2018/03/30. PubMed PMID: 29593684; PubMed Central PMCID: PMCPMC5861770.
  • Baker CJ, Kasper DL. Group B streptococcal vaccines. Rev Infect Dis. 1985;7(4):458–467. doi: 10.1093/clinids/7.4.458. Epub 1985/07/01. PubMed PMID: 3898306.
  • Palazzi DL, Rench MA, Edwards MS, et al. Use of type V group B streptococcal conjugate vaccine in adults 65–85 years old. J Infect Dis. 2004;190(3):558–564. doi: 10.1086/422010. Epub 2004/07/10. PubMed PMID: 15243932.
  • CLSI. M100 Performance Standards for Antimicrobial Susceptibility Testing: Clinical and Laboratory Standards Institute. (2020). [20 April 2021]. Available from: https://www.nih.org.pk/wp-content/uploads/2021/02/CLSI-2020.pdf
  • Ke D, Menard C, Picard FJ, et al. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem. 2000;46(3):324–331. doi: 10.1093/clinchem/46.3.324. PubMed PMID: 10702518.
  • Srivastava S, Singh V, Kumar V, et al. Identification of regulatory elements in 16S rRNA gene of Acinetobacter species isolated from water sample. Bioinformation. 2008;3(4):173–176. doi: 10.6026/97320630003173. Epub 2009/02/25. PubMed PMID: 19238242; PubMed Central PMCID: PMCPMC2639665.
  • Sukhnanand S, Dogan B, Ayodele MO, et al. Molecular subtyping and characterization of bovine and human Streptococcus agalactiae isolates. J Clin Microbiol. 2005;43(3):1177–1186. doi: 10.1128/JCM.43.3.1177-1186.2005 PubMed PMID: 15750080; PubMed Central PMCID: PMCPMC1081236.
  • Duarte RS, Bellei BC, Miranda OP, et al. Distribution of antimicrobial resistance and virulence-related genes among Brazilian group B streptococci recovered from bovine and human sources. Antimicrob Agent Chemother. 2005;49(1):97–103. doi: 10.1128/AAC.49.1.97-103.2005. PubMed PMID: 15616281; PubMed Central PMCID: PMCPMC538850.
  • Hall T. Bioedit: A user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT. Nucleic Acids Sympos Series. 1999;41:95–98.
  • Graux E, Hites M, Martiny D, et al. Invasive group B Streptococcus among non-pregnant adults in Brussels-capital region, 2005–2019. Eur J Clin Microbiol Infect Dis. 2021;40(3):515–523. doi: 10.1007/s10096-020-04041-0. PubMed PMID: 32944894; PubMed Central PMCID: PMCPMC7498195.
  • Jiang H, Chen M, Li T, et al. Molecular characterization of Streptococcus agalactiae causing community- and hospital-acquired infections in Shanghai, China. Front Microbiol. 2016;7:1308, doi: 10.3389/fmicb.2016.01308 PubMed PMID: 27625635; PubMed Central PMCID: PMCPMC5003847.
  • Wang YH, Chen CL, Hou JN, et al. Serotype distribution and resistance genes associated with macrolide and fluoroquinolone resistance in Streptococcus agalactiae isolates from a hospital in southern Taiwan. Biomed J. 2015;38(3):215–220. doi: 10.4103/2319-4170.138306. PubMed PMID: 25179723.
  • Al Safadi R, Amor S, Hery-Arnaud G, et al. Enhanced expression of lmb gene encoding laminin-binding protein in Streptococcus agalactiae strains harboring IS1548 in scpB-lmb intergenic region. PLoS One. 2010;5(5):e10794). doi: 10.1371/journal.pone.0010794. PubMed PMID: 20520730.
  • Palacios-Saucedo GDC, Rivera-Morales LG, Vazquez-Guillen JM, et al. Genomic analysis of virulence factors and antimicrobial resistance of group B Streptococcus isolated from pregnant women in northeastern Mexico. PLoS One. 2022;17(3):e0264273, doi: 10.1371/journal.pone.0264273 Epub 2022/03/17. PubMed PMID: 35294459; PubMed Central PMCID: PMCPMC8926241.
  • Chandran A. National Diabetes Registry Report, 2013-20192020.
  • Arias B, Kovacec V, Vigliarolo L, et al. Epidemiology of invasive infections caused by Streptococcus agalactiae in Argentina. Microb Drug Resist. 2022;28(3):322–329. doi: 10.1089/mdr.2021.0071. Epub 2022/01/11. PubMed PMID: 35007436.
  • Morozumi M, Wajima T, Takata M, et al. Molecular characteristics of group B streptococci isolated from adults with invasive infections in Japan. J Clin Microbiol. 2016;54(11):2695–2700. doi: 10.1128/JCM.01183-16. PubMed PMID: 27558182; PubMed Central PMCID: PMCPMC5078545.
  • Murdoch DR, Reller LB. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob Agent Chemother. 2001;45(12):3623–3624. doi: 10.1128/AAC.45.12.3623-3624.2001. PubMed PMID: 11709354; PubMed Central PMCID: PMCPMC90883.
  • Matsubara K, Nishiyama Y, Katayama K, et al. Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan. J Antimicrob Chemother. 2001;48(4):579–582. doi: 10.1093/jac/48.4.579 PubMed PMID: 11581242.
  • Ruess M, Muller U, Sander A, et al. Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital. Scand J Infect Dis. 2000;32(6):623–626. doi: 10.1080/003655400459522. PubMed PMID: 11200371.
  • Kimura K, Suzuki S, Wachino J, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother. 2008;52(8):2890–2897. doi: 10.1128/AAC.00185-08. PubMed PMID: 18490507; PubMed Central PMCID: PMCPMC2493108.
  • Hayes K, O'Halloran F, Cotter L. A review of antibiotic resistance in group B Streptococcus: the story so far. Crit Rev Microbiol. 2020;46(3):253–269. doi: 10.1080/1040841X.2020.1758626. Epub 2020/05/05. PubMed PMID: 32363979.
  • Gaudreau C, Lecours R, Ismail J, et al. Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone. J Antimicrob Chemother. 2010;65(3):594–595. doi: 10.1093/jac/dkp458. Epub 2009/12/22. PubMed PMID: 20022939.
  • Yi A, Kim CK, Kimura K, et al. First case in Korea of group B streptococcus with reduced penicillin susceptibility harboring Amino acid substitutions in penicillin-binding protein 2X. Ann Lab Med. 2019;39(4):414–416. doi: 10.3343/alm.2019.39.4.414. Epub 2019/02/28. PubMed PMID: 30809991; PubMed Central PMCID: PMCPMC6400725.
  • van der Linden M, Mamede R, Levina N, et al. Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany. J Antimicrob Chemother. 2020;75(2):296–299. doi: 10.1093/jac/dkz465. Epub 2019/11/20. PubMed PMID: 31740946; PubMed Central PMCID: PMCPMC6966095.
  • Tulyaprawat O, Pharkjaksu S, Shrestha RK, et al. Emergence of multi-drug resistance and Its association with uncommon serotypes of Streptococcus agalactiae isolated from non-neonatal patients in Thailand. Front Microbiol. 2021;12:719353, doi: 10.3389/fmicb.2021.719353. Epub 2021/09/28. PubMed PMID: 34566923; PubMed Central PMCID: PMCPMC8456118.
  • Crespo-Ortiz Mdel P, Castaneda-Ramirez CR, Recalde-Bolanos M, et al. Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study. BMC Infect Dis. 2014;14:428, doi: 10.1186/1471-2334-14-428 PubMed PMID: 25086463; PubMed Central PMCID: PMCPMC4131052.
  • Li J, Ji W, Gao K, et al. Molecular characteristics of group B Streptococcus isolates from infants in southern mainland China. BMC Infect Dis. 2019;19(1):812, doi: 10.1186/s12879-019-4434-0. Epub 2019/09/20. PubMed PMID: 31533652; PubMed Central PMCID: PMCPMC6751900.
  • Yao Z, Jiayin W, Xinyi Z, et al. Identification of Group B streptococcus serotypes and genotypes in late pregnant women and neonates that Are associated with neonatal early-onset infection in a south China population. Front Pediatr. 2020;8:265, doi: 10.3389/fped.2020.00265. Epub 2020/06/17. PubMed PMID: 32537444; PubMed Central PMCID: PMCPMC7266973.
  • Teatero S, McGeer A, Low DE, et al. Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada. J Clin Microbiol. 2014;52(5):1441–1447. doi: 10.1128/JCM.03554-13. Epub 2014/02/21. PubMed PMID: 24554752; PubMed Central PMCID: PMCPMC3993709.